ArticleAmerican journal of translational research2026
A nomogram for predicting insulin resistance in polycystic ovary syndrome based on serum amino acid profiles and anti-Müllerian hormone.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesInsulin resistance (IR) worsens metabolic and reproductive outcomes in polycystic ovary syndrome (PCOS). This study aimed to develop and validate a nomogram incorporating serum amino acid profiles and anti-Müllerian hormone (AMH) for predicting IR in PCOS.
methodsA retrospective observational analysis was performed on 434 PCOS patients treated at The Fourth Hospital of Shijiazhuang between January 2022 and January 2026. Patients were classified as IR+ (n=184) or IR- (n=250) using a homeostasis model assessment of insulin resistance (HOMA-IR) cutoff of 2.69 and were chronologically assigned to training (n=259) and validation (n=175) cohorts. Anthropometric parameters, hormone levels and serum amino acid concentrations were measured. Multivariable logistic regression identified independent predictors for nomogram development. Receiver operating characteristic (ROC) analysis, calibration plot, bootstrap resampling and decision curve analysis (DCA) were applied to evaluate the model's performance.
resultsMultivariable analysis identified body mass index (odds ratio [OR]=1.357, 95% confidence interval [CI]: 1.180-1.561), waist circumference (OR=1.096, 95% CI: 1.053-1.141), AMH (OR=0.931, 95% CI: 0.879-0.986), leucine (OR=1.028, 95% CI: 1.012-1.044), isoleucine (OR=1.075, 95% CI: 1.045-1.107), valine (OR=1.015, 95% CI: 1.009-1.022) and tyrosine (OR=1.046, 95% CI: 1.004-1.089) as independent predictors. The nomogram demonstrated excellent discrimination in training (area under the curve [AUC]=0.945) and validation (AUC=0.917) cohorts, with good calibration (Hosmer-Lemeshow P=0.554) and clinical utility on DCA.
conclusionThis nomogram, integrating anthropometric measures, serum AMH and four amino acids, provides an accurate tool for the early identification of IR in PCOS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.